Ka Ka Ting

University of Sydney — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.0kcitations34works23.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(9), Cell Adhesion Molecules Research(8), Cancer Immunotherapy and Biomarkers(7), Immune cells in cancer(7), Alzheimer's disease research and treatments(4)

Publications34 total

Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis
Journal of Translational Medicine·2024· 23 citedOpen Access
Vascular senescence and leak are features of the early breakdown of the blood–brain barrier in Alzheimer’s disease models
GeroScience·2023· 55 citedOpen Access
Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate
Frontiers in Immunology·2023· 7 citedOpen Access
Endothelial cell senescence — understanding aging and disease
Current Opinion in Physiology·2023· 1 cited
Supplemental figures 1-6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Supplemental figures 1-6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Table and material & methods from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
FigS1,FigS2,FigS3,FigS4,FigS5,FigS6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Data from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Table and material & methods from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Data from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
FigS1,FigS2,FigS3,FigS4,FigS5,FigS6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking
Cancers·2021· 21 citedOpen Access
The aging endothelium
Vascular Biology·2021· 33 citedOpen Access
IDDF2020-ABS-0166 Novel mirna-based drug CD5–2 reduces liver tumour growth in diethylnitrosamine (DEN)-treated mice by normalising tumour vasculature and altering immune infiltrate
Abstracts·2020Open Access
The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours
Cancer Letters·2020· 25 citedOpen Access
Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice
PLoS Biology·2020· 47 citedOpen Access
YAP and the RhoC regulator ARHGAP18, are required to mediate flow-dependent endothelial cell alignment
Cell Communication and Signaling·2020· 22 citedOpen Access
Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2019· 40 cited
ARHGAP18: A Flow‐Responsive Gene That Regulates Endothelial Cell Alignment and Protects Against Atherosclerosis
Journal of the American Heart Association·2019· 20 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jennifer R. Gamble(25), Mathew A. Vadas(24), Jinbiao Chen(16), Jia Li(13), Geoffrey W. McCaughan(13), Paul Coleman(12), Victoria C. Cogger(11), Yang Zhao(10), Shin Foong Ngiow(9), Jeff Holst(9), Georges E. Grau(9), Shom Goel(9), Thorleif Muller(9), Elisabetta Dejana(9), Mark J. Smyth(9), Ruth Ganß(9), Bruce J. Brew(8), Gilles J. Guillemin(8), Anna Johansson-Percival(8), Yang Zhao(7)